Nuclear factor NF-κB in myocardium: Developmental expression of subunits and activation by interleukin-1β in cardiac myocytes in vitro

Cardiovascular Research

Volumn 39, Issue 2, 1998, Pages 434-441

  Norman, David A M ^a   Yacoub, Magdi H ^a   Barton, Paul J R ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Cardiac myocyte; Development; Human; Interleukin 1 ; NF B; Rat

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; PROTEIN SUBUNIT;

ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; CYTOKINE RELEASE; DNA BINDING; ELECTROPHORETIC MOBILITY; HEART DEVELOPMENT; HEART MUSCLE; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRANSCRIPTION REGULATION;

ANIMALS; ANIMALS, NEWBORN; CELL NUCLEUS; CELLS, CULTURED; DNA-BINDING PROTEINS; ELECTROPHORESIS; FETAL HEART; HUMANS; I-KAPPA B PROTEINS; IMMUNOBLOTTING; INTERLEUKIN-1; ISOMERISM; MYOCARDIUM; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 0032145938     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(98)00118-7     Document Type: Article

References (47)

1. [1] Baeuerle PA, Baltimore D. NF-κB: Ten years after. Cell 1996;87:13-20.
2. [2] Thanos D, Maniatis T. NF-κB: A lesson in family values. Cell 1995;80:529-532.
3. [3] Baldwin Jr. AS. The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol 1996;14:649-681.
4. [4] Morishita R, Sugimoto T, Aoki M, et al. In vivo transfection of cis element "decoy" against nuclear factor-κB binding site prevents myocardial infarction. Nat Med 1997;3(8):894-899.
5. [5] Oddis CV, Finkel MS. NF-κB and GTP cyclohydrolase regulate cytokine-induced nitric oxide production by cardiac myocytes. Am J Physiol 1996;270:H1864-H1868.
6. [6] Kacimi R, Long CS, Karliner JS. Chronic hypoxia modulates the interleukin-1β-stimulated inducible nitric oxide synthase pathway in cardiac myocytes. Circulation 1997;96(6):1937-1943.
7. [7] Peng M, Huang L, Xie Z, Huang W, Askari A. Oxidant-induced activations of nuclear factor-κB and activator protein-1 in cardiac myocytes. Cell Mol Biol Res 1995;41:189-197.
8. [8] Chandrasekar B, Freeman GL. Induction of nuclear factor κB and activation protein 1 in postischemic myocardium. FEBS Lett 1997;401(1):30-34.
9. [9] Luss H, Watkins SC, Freeswick PD, et al. Characterization of inducible nitric oxide synthase expression in endotoxemic rat cardiac myocytes in vivo and following cytokine exposure in vitro. J Mol Cell Cardiol 1995;27:2015-2029.
10. [10] Shindo T, Ikeda U, Ohkawa F, et al. Nitric oxide synthesis in cardiac myocytes and fibroblasts by inflammatory cytokines. Cardiovasc Res 1995;29:813-819.
11. [11] Tsujino M, Hirata Y, Imai E, et al. Induction of nitric oxide synthase gene by interleukin-1β in cultured rat cardiomyocytes. Circulation 1994;90:375-383.
12. [12] Harding P, Carretero OA, La Pointe MC. Effects of interleukin-1ß and nitric oxide on cardiac myocytes. Hypertension 1995;25:421-430.
13. [13] Xie Q, Kashiwabara Y, Nathan C. Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J Biol Chem 1994;269:4705-4708.
14. [14] Yamauchi-Takihara K, Ihara Y, Ogata A, et al. Hypoxic stress induces cardiac myocytes derived interleukin-6. Circulation 1995;91:1520-1524.
15. [15] Matsusaka T, Fujikawa K, Nishio Y, et al. Transcription factors NF-IL6 and NF-κB synergistically activate transcription of the inflammatory cytokines, interleukin 6, and interleukin 8. Proc Natl Acad Sci USA 1993;90:10193-10197.
16. [16] Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NF-κB. Annu Rev Cell Biol 1994;10:405-455.
17. [17] Miyamoto S, Verma IM. Rel/NF-κB/IκB story. Adv Cancer Res 1995;66:255-292.
18. [18] Baeuerle PA, Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immunol 1994;12:141-179.
19. [19] Sivasubramanian N, Adhikary G, Sil PC, Sen S. Cardiac myotrophin exhibits rel/NF-κB interacting activity in vitro. J Biol Chem 1996;271:2812-2816.
20. [20] Kunz D, Walker G, Eberhardt W, Nitsch D, Pfeilschifter J. Interleukin 1β-induced expression of nitric oxide synthase in rat renal mesangial cells is suppressed by cyclosporin A. Biochem Biophys Res Commun 1995;216:438-446.
21. [21] Muraoka K, Fujimoto K, Sun X, et al. Immunosuppressant FK506 induces interleukin-6 production through the activation of transcription factor nuclear factor (NF)-κB. J Clin Invest 1996;97:2433-2439.
22. [22] Weil R, Laurent-Winter C, Israel A. Regulation of IκB-β degradation. J Biol Chem 1997;272:9942-9949.
23. [23] Thompson JE, Phillips RJ, Erdjument-Bromage H, Tempst P, Ghosh S. IκB-β regulates the persistent response in a biphasic activation of NF-κB. Cell 1995;80:573-582.
24. [24] Han Y, Brasier AR. Mechanism for biphasic rel A NF-κB1 nuclear translocation in tumor necrosis factor α-stimulated hepatocytes. J Biol Chem 1997;272:9825-9832.
25. [25] Whiteside ST, Epinat J, Rice NR, Israel A. IκB-ε, a novel member of the IκB family, controls RelA and cRel NF-κB activity. EMBO J 1997;16:1413-1426.
26. [26] Li Z, Nabel GJ. A new member of the IκB protein family, IκB-∈, inhibits RelA (p65)-mediated NF-κB transcription. Mol Cell Biol 1997;17(10):6184-6190.
27. [27] Chen ZJ, Parent L, Maniatis T. Site-specific phosphorylation of IκB-α by a novel ubiquitination-dependent protein kinase activity. Cell 1996;84:853-862.
28. [28] Schmid RM, Liptay S, Betts JC, Nabel GJ. Structural and functional analysis of NF-κB. J Biol Chem 1994;269:32162-32167.
29. [29] Rice NR, MacKichan ML, Israel A. The precursor of NF-κB p50 has IκB-like functions. Cell 1992;71:243-253.
30. [30] Iwaki K, Sukhatme VP, Shubeita HE, Chien KR. Alpha-and beta-adrenergic stimulation induces distinct patterns of immediate early gene expression in neonatal rat myocardial cells. J Biol Chem 1990;265:13809-13817.
31. [31] Rosette C, Karin M. Cytoskeletal control of gene expression: depolymerization of microtubules activates NF-κB. J Cell Biol 1995;128(6):1111-1119.
32. [32] Oddis CV, Simmons RL, Hattler BG, Finkel MS. cAMP enhances inducible nitric oxide synthase mRNA stability in cardiac myocytes. Am J Physiol 1995;269:H2044-H2050.
33. [33] Rice NR, Ernst MK. In vivo control of NF-κB activation by IκB-α. EMBO J 1993;12(12):4685-4695.
34. [34] Legato MJ. Cellular mechanisms of normal growth in the mammalian heart. I. Qualitative and quantitative features of ventricular architecture in the dog from birth to five months of age. Circ Res 1979;44:250-262.
35. [35] van der Hoff MJB, Deprez RHL, Monteiro M, et al. Developmental changes in rat cardiac DNA, RNA and protein tissue base: implications for the interpretation of changes in gene expression. J Mol Cell Cardiol 1997;29:629-639.
36. [36] Stein B, Frank P, Schmilz W, Scholz H, Thoenes M. Endotoxin and cytokines induce direct cardiodepressive effects in mammalian cardiomyocytes via induction of nitric oxide synthase. J Mol Cell Cardiol 1996;28:1631-1639.
37. [37] Thaik CM, Calderone A, Takahashi N, Colucci WS. Interleukin-1β modulates the growth and phenotype of neonatal rat cardiac myocytes. J Clin Invest 1995;96:1093-1099.
38. [38] Palmer JN, Hartogensis WE, Patten M, Fortuin FD, Long CS. Interleukin-1β induces cardiac myocyte growth but inhibits cardiac fibroblast proliferation in culture. J Clin Invest 1995;95:2555-2564.
39. [39] La Pointe MC, Sitkins JR. Mechanisms of interleukin-1β regulation of nitric oxide synthase in cardiac myocytes. Hypertension 1996;27(3):709-714.
40. [40] McTiernan CF, Lemster BH, Frye C, et al. Interleukin-1β inhibits phospholamban gene expression in cultured cardiomyocytes. Circ Res 1997;81(4):493-503.
41. [41] Patten M, Hartogensis WE, Long CS. Interleukin-1β is a negative transcriptional regulator of α-adrenergic induced gene expression in cultured cardiac myocytes. J Biol Chem 1996;271:21134-21141.
42. [42] Balligand J, Ungureanu-Longrois D, Simmons WW, et al. Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. J Biol Chem 1994;269:27580-27588.
43. [43] Hattori Y, Nakanishi N, Kasai K. Role of nuclear factor KB in cytokine-induced nitric oxide and tetrahydrobiopterin synthesis in rat neonatal cardiac myocytes. J Mol Cell Cardiol 1997;29:1585-1592.
44. [44] Imbert V, Rupee RA, Livoisi A, et al. Tyrosine phosphorylation of IκB-α activates NF-κB without proteolytic degradation of IκB-α. Cell 1996;86:787-798.
45. [45] Miyamoto S, Maki M, Schmitt MJ, Hatanaka M, Verma IM. Tumor necrosis factor α-induced phosphorylation of IκB-α is a signal for its degradation but not dissociation from NF-κB. Proc Natl Acad Sci USA 1994;91:12740-12744.
46. [46] Tran K, Merika M, Thanos D. Distinct functional properties of IκB-α and IκB-β. Mol Cell Biol 1997;17(9):5386-5399.
47. [47] Johnson DR, Douglas I, Jahnke A, Ghosh S, Prober JS. A sustained reduction in IκB-β may contribute to persistent NF-κB activation in human endothelial cells. J Biol Chem 1996;271(27):16317-16322.